...
首页> 外文期刊>Journal of pharmacy practice >Toxicology and Management of Novel Psychoactive Drugs
【24h】

Toxicology and Management of Novel Psychoactive Drugs

机译:新型精神药物的毒理学与管理

获取原文
获取原文并翻译 | 示例

摘要

Health care providers are seeing an increased number of patients under the influence of several new psychoactive drug classes. Synthetic cannabinoids, cathinones, and piperazines are sought by users for their psychoactive effects, perceived safety profile, minimal legal regulations, and lack of detection on routine urine drug screening. However, these drugs are beginning to be recognized by the medical community for their toxic effects. The neuropsychiatric and cardiovascular toxicities are among the most common reasons for emergency medical treatment, which in some cases, can be severe and even life-threatening. Management strategies are often limited to supportive and symptomatic care due to the limited published data on alternative treatment approaches. The purpose of this article is to offer health care providers, emergency medical personnel in particular, an awareness and understanding of the dangers related to some of the new psychoactive drugs of abuse. The background, pharmacology, toxicity, management, detection, and legal status of each class will be discussed.
机译:在几种新型精神药物的影响下,医疗保健提供者看到的患者数量有所增加。使用者寻求合成大麻素,卡西酮和哌嗪类药物的心理作用,可感知的安全性,最低限度的法律法规以及缺乏常规尿液筛查的检测手段。然而,这些药物由于其毒性作用而开始被医学界所认可。神经精神病学和心血管毒性是紧急医疗的最常见原因,在某些情况下,这种医疗可能非常严重,甚至危及生命。由于有关替代治疗方法的公开数据有限,因此管理策略通常仅限于支持性和对症治疗。本文的目的是为医疗保健提供者,尤其是紧急医疗人员提供与某些新型精神活性药物滥用相关的危险的认识和理解。每个类别的背景,药理学,毒性,管理,检测和法律地位都将进行讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号